微信直播

AME新书|《Hepatocellular Carcinoma》新书即将面世,译者招募正式启动

Published at: 2015年第1卷第S1期

关键词:

编者按:肝癌是我国常见的恶性肿瘤之一,为回顾国内外多年来在肝癌诊疗上遇到的问题以及取得的研究成果,AME Publishing Company 邀请了美国、日本、意大利、中国等 14 个国家 160 多位专家共同编撰《肝癌》(Hepatocellular Carcinoma)一书,并将在全球同步推出其中英文版,欢迎广大医学工作者参与到此书中文版的翻译工作中,成为本书译者,还将获赠本书中英文版各一本!

书简介

本书围绕肝癌诊断、治疗的问题、学科进展进行回顾,前半部分从肝癌的流行病学和危险因素、发病机制、分子基础说起,让读者对当前研究成果有所了解。后半部分对手术、局部治疗和系统性治疗等治疗知识进行了更新。深入浅出,图文并茂,形象易懂:

  • 第一部分 肝细胞癌的概述

  • 第二部分 不同国家和地区的肝细胞癌现状

  • 第三部分 肝细胞癌的基础研究

  • 第四部分 肝细胞癌早期诊断的分子标志物

  • 第五部分 肝细胞癌的手术切除和肝移植治疗

  • 第六部分 肝细胞癌的消融治疗

  • 第七部分 肝细胞的放射、药物和靶向治疗

  • 第八部分 肝细胞癌的预后和术后并发症

 

编风采

蔡秀军,主任医师,教授,浙江大学医学院附属邵逸夫医院院长。知名外科专家,浙江大学微创外科研究所所长,浙江省腔镜技术研究重点实验室主任,浙江省腔镜技术重点创新团队负责人,中华医学会外科分会常务委员、中华医学会外科分会肝脏外科学组副组长、中国抗癌协会胰腺癌专业委员会副主任委员、美国外科学院委员、国际肝胆胰外科协会委员、亚洲内镜腔镜外科协会委员。

Patrick Pessaux, MD, PhD, The Hepato-Biliary and Pancreatic Surgical Unit, Nouvel Hopital Civil (NHC), France.Professor Patrick Pessaux is the Head of the Hepato-Biliary and Pancreatic surgical Unit in the Department of Digestive and Endocrine Surgery at the University Hospital of Strasbourg, a Professor at the University of Medicine of Strasbourg, and a Researcher in the field of hepato-biliairy and pancreatic diseases and of minimally invasive surgery at the IRCAD Institute of Strasbourg.

 

认领文章

编号

题目

1

Hepatocellular carcinoma: present and future

2

Hepatocellular carcinoma: expanding the horizon

3

Guidelines for the management of hepatocellular carcinoma: still in need of standardization

4

New insights in hepatocellular carcinoma: from bench to bedside

5

Hepatocellular carcinoma in the modern era: transplantation, ablation, open surgery or minimally invasive surgery? —A multidisciplinary personalized decision

6

Management of hepatocellular carcinoma should consider both tumor factors and background liver factors

7

A bridge between multi-omics data and the management of hepatocellular carcinoma

8

A review of hepatocellular carcinoma (HCC) staging systems

9

Hepatocellular carcinoma: what is happening everywhere?

10

Features and treatment options of Chinese hepatocellular carcinoma

11

Status of hepatocellular carcinoma in South Korea

12

Current status of hepatocellular carcinoma in Japan

13

Hepatocellular carcinoma in India

14

Status of hepatocellular carcinoma in Gulf region

15

Risk factors for developing hepatocellular carcinoma in Egypt

16

Status of hepatocellular cancer in Europe

17

Current status of hepatocellular carcinoma in the United States

18

Profiling HBV integrations in hepatocellular carcinoma cancer

19

Cellular and molecular mechanisms of hepatic fibrogenesis leading to liver cancer

20

Alcoholic liver disease- Hepatocellular carcinoma transformation

21

Viral hepatitis, non-alcoholic fatty liver disease and alcohol as risk factors for hepatocellular carcinoma

22

Vitamin E in prevention against hepatocellular carcinoma: right type, right dose and right population

23

Nutrition and metabolism in hepatocellular carcinoma

24

Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?

25

Statins: emerging role in chemoprevention for hepatocellular carcinoma?

26

Hepatocellular carcinoma: the rising tide from east to west—a review of epidemiology, screening and tumor markers

27

Novel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?

28

Serum Dickkopf-1 as a biomarker for the diagnosis of hepatocellular carcinoma

29

DKK1 as a serum biomarker for hepatocellular carcinoma

30

Midkine as a new diagnostic tool in hepatocellular carcinoma

31

TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis

32

Serum biomarkers for early diagnosis of hepatocellular carcinoma

33

Surgical resection for hepatocellular carcinoma

34

Laparoscopic liver resection: basic skills for peripheral lesions

35

Laparoscopic resection for hepatocellular carcinoma: comparison between Middle Eastern and Western experience

36

Laparoscopic resection for hepatocellular carcinoma: eastern and western experiences

37

Robotic liver surgery

38

Liver transplantation for hepatocellular carcinoma

39

Review on liver transplant for hepatocellular carcinoma

40

Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation

41

Liver transplantation for hepatocellular carcinoma: are international guidelines possible?

42

Percutaneous therapies of hepatocellular carcinoma—an update

43

High-intensity focused ultrasound (HIFU) for the treatment of hepatocellular carcinoma: is it time to abandon standard ablative percutaneous treatments?

44

Comparison of high-intensity focused ultrasound therapy and radiofrequency ablation for recurrent hepatocellular carcinoma

45

Stereotactic body radiation therapy for primary hepatic malignancies and metastases to liver: a technical and literature review

46

C-arm dual-phase cone-beam CT: a revolutionary real-time imaging modality to assess drug-eluting beads TACE success in liver cancer patients

47

Proton therapy for hepatocellular carcinoma

48

Systemic therapy for hepatocellular carcinoma

49

Beyond chemotherapy: systemic treatment options for hepatocellular carcinoma

50

Current status of bevacizumab for advanced hepatocellular carcinoma

51

Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules

52

Transcatheter embolization therapy in liver cancer: an update of clinical evidences

53

Management of liver cirrhosis in patients with hepatocellular carcinoma

54

Quality of life and hepatocellular carcinoma

55

Prediction of postoperative liver failure in patients diagnosed with hepatocellular carcinoma using 99mTc-GSA SPECT/CT

56

Post-hepatectomy liver failure

57

Importance of tumor/stroma interactions in prognosis of hepatocellular carcinoma

58

Hepatocellular carcinoma: How could we imagine the future research?

 

认领方式

方法一:点击阅读原文登录系统认领(欢迎关注公众号「AME科研时间」amegroups)。

方法二:点击/复制AME认领系统链接:(推荐)

http://rl.amegroups.com/User/Assignment?Type=0001&HidTaskNO=HCC_001

Step 1. 尚未注册账号的认领者需要【注册】并激活账号:点击链接(http://rl.amegroups.com)。

Step 2. 用户登录并进入【翻译】板块,选择【NO.】:如HCC_001, 点击认领即可;或查询可认领文章,从【待认领】文章中选择认领。

Step 3. 认领成功后,请选择【下载】来获取原文,同时请务必查看【要求】,按要求翻译文章。有问题请联系下列邮箱:kysj@amepc.org 。每人最多认领两篇。

认领截止日期:本次认领长期有效,直至认领完毕。

认领成功后,请在认领成功后的三周内将翻译稿及个人简介发送到 kysj@amepc.org。

 

凡翻译质量通过审核的译者,可获得:

 

  1. 每翻译一篇文章,即可获得价值 200 元人民币的科研时间积分(200 快币)以及免费登录视频数据库 ASVIDE,观看手术视频(积分限免)。

  2. 译者署名。

  3. 获赠本书中英文版各一本。

doi:

10.3978/kysj.2014.1.1395
comments powered by Disqus

附件